Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 29
- Clinical Research
SOMAÍ and Universidade Lusófona Publish Peer-Reviewed Study Validating Full-Spectrum Oil Consistency
SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specialising in cannabinoid-based medicines, together with Universidade Lusófona, has published their 4th peer-reviewed study titled “Genotype and chemotype insights of high-THC medicinal Cannabis sativa L.: the role of SSR markers in the identification of cultivars” in the Journal of Cannabis Research.
- Medical Cannabis
Spanish Pharmacists Appeal Hospital-Only Cannabis Rule as Key Regulatory Deadline Passes Unmet
Spain represents one of the most exciting incoming additions to the European medical cannabis market this year, as one of the continent’s largest producers finally moves toward domestic patient access after years of hard-fought advocacy.
- Industry Trends
Inside the Medical Cannabis Police Guidance: Cancards, Driving, and What Patients Need to Know
Earlier this week, the first official guidance on medical cannabis for police officers in England and Wales was made public.
- Medical Cannabis
UK Police Finally Get Official Medical Cannabis Guidance More Than 7 Years After Legalisation
Over seven years after medical cannabis was legalised in the UK, the National Police Chiefs’ Council has approved the first official guidance for medical cannabis.
- International Regulation
Germany’s Medical Cannabis Bill Faces Critical Test as Experts Warn of ‘Unenforceable’ Framework
As Trump’s rescheduling executive order dominated the cannabis industry’s attention over the holiday period, Germany’s controversial medical cannabis bill quietly entered its most critical phase.
- Clinical Research
Industry Leaders React to Historic Cannabis Rescheduling
President Donald Trump’s executive order directing federal agencies to move cannabis from Schedule I to Schedule III of the Controlled Substances Act represents the most significant shift in US drug policy in over half a century.
- Clinical Research
Cannabis Rescheduling is Here: Trump Signs Executive Order to Move Cannabis to Schedule III
After two years of speculation, rumours, stock swings, broken promises, and political theatre, President Donald Trump officially signed an executive order (EO) to push cannabis rescheduling through on Thursday (December 18).
- CBD Market
CBD Company Founder Wins £137k Unfair Dismissal Award Amid Cannim Group Collapse
Last month, international cannabis operator Cannim collapsed, calling in administrators to sift through the company’s remaining assets and attempt to find tens of millions of dollars to satisfy its increasingly frustrated creditors.
- Clinical Research
Veterans and Medical Cannabis: Can Private Clinics Fill NHS Treatment Gaps?
The UK’s health service is fighting to keep its head above water, yet with a record-breaking winter flu pandemic sweeping the nation, and a looming industrial action set to see thousands of resident doctors walk out later this week, the water level is rising rapidly.
- Industry Trends
Could Trump Actually Reschedule Cannabis This Time?
Cannabis Rescheduling fervour has once again reached dramatic levels following media reports that President Donald Trump is considering pushing through the long-touted move via an executive order.
- Clinical Research
‘Blockbuster’ Cannabis Drug To Be Released in 2026
Findings from the successful trials of a new, multi-compound, cannabis medicine look set to deliver a major breakthrough for the world’s half-a-billion chronic low back pain (CLB) sufferers.
- Medical Cannabis
Glass Pharms Announces New UK Supply Deals as it launches Premium Range
Glass Pharms, the UK-based cultivator of medical cannabis flower, has announced a supply agreement with Integro Clinic & IPS Pharmacy to provide them with a new premium range of Glass Pharms-branded CBPMs made with domestically grown flower cultivated at the Glass Pharms facility.
